Integrin α9 gene promoter is hypermethylated and downregulated in nasopharyngeal carcinoma-Reference-Cited by-同舟云学术

Integrin α9 gene promoter is hypermethylated and downregulated in nasopharyngeal carcinoma

Published:2015-09-08 Issue:31 Volume:6 Page:31493-31507
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Nawaz Imran¹²,Hu Li-Fu¹,Du Zi-Ming¹³,Moumad Khalid⁴⁵,Ignatyev Ilya¹,Pavlova Tatiana V.¹,Kashuba Vladimir¹,Almgren Malin⁶⁷,Zabarovsky Eugene R.¹⁸,Ernberg Ingemar¹

Affiliation:

1. Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden

2. Department of Microbiology, Faculty of Life Sciences, University of Balochistan, Quetta, Pakistan

3. State Key Laboratory of Oncology in South China, and Department of Pathology, Sun Yat-Sen University Cancer Center, Guangzhou, P.R. China

4. Department of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany

5. Oncovirology Laboratory, Institut Pasteur du Maroc, Casablanca, Morocco

6. Department Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden

7. Centre for Molecular Medicine, Stockholm, Sweden

8. Department of Clinical & Experimental Medicine, Division of Cell Biology, Linköping University, Linköping, Sweden

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The characteristics and the multiple functions of integrin β1 in human cancers;Journal of Translational Medicine;2023-11-06

2. ITGA9: Potential Biomarkers and Therapeutic Targets in Different Tumors;Current Pharmaceutical Design;2022-05

3. Loss of Integrin α9β1 on Tumor Keratinocytes Enhances the Stromal Vasculature and Growth of Cutaneous Tumors;Journal of Investigative Dermatology;2021-11

4. Promoter Hypermethylation of Tumor Suppressor Genes Located on Short Arm of the Chromosome 3 as Potential Biomarker for the Diagnosis of Nasopharyngeal Carcinoma;Diagnostics;2021-08-03

5. Integrin-α9β1 as a Novel Therapeutic Target for Refractory Diseases: Recent Progress and Insights;Frontiers in Immunology;2021-03-15